You are here

AusPAR: Lanadelumab

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

19 March 2020
AusPAR Details
AusPAR
Active Ingredient
Lanadelumab
Product Name
Takhzyro
Sponsor
Shire Australia Pty. Ltd
Submission Number
PM-2017-01464-1-2
Submission Type
New biological entity
Decision
Approved
AusPAR Date
4 March 2020
Publication Date

19 March 2020